EUVIMEDEUVIMED entdecken
Crossref

Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases

Andrea Zoia iD, Francesca Busato, Michele Drigo

Journal of Veterinary Emergency and Critical Care · 2024

DOI: 10.1111/vec.13408 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Emergency and Critical Care, 2024. Verfasst von Andrea Zoia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, San Marco Veterinary Clinic, Veggiano, Italy. Hauptthemen laut MEDLINE: Dog Diseases, Immunoglobulins, Intravenous, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe the short‐term response, early prognostic markers, and survival after treatment of canine immune‐mediated thrombocytopenia (ITP) with human intravenous immunoglobulin (hIVIG) and methylprednisolone.

Design

Retrospective cohort study. Settings Private referral veterinary medical center. Animals Twenty‐seven client‐owned dogs with primary or secondary ITP.

Interventions

All dogs received 2 mg/kg IV methylprednisolone once daily and a single infusion of 5% hIVIG administered over 6–12 hours. Measurements and Main Results A substantial increase in platelet count within 60 ± 12 hours post‐hIVIG infusion (T 60 ) was observed in 19 of the 27 (70%) dogs with ITP (responders). Thirty‐four variables, including serum immunoglobulin (Ig) G concentration 24 ± 12 hours post‐hIVIG infusion (T 24 IgG) and increase in serum IgG concentration 24 ± 12 hours post‐hIVIG infusion (T 24 Δ IgG ), were compared between responders and nonresponders at 5 different time points. Mortality rates of responders and nonresponders were evaluated 14 days post‐hIVIG infusion. Serum T 24 IgG and serum T 24 Δ IgG were both significantly higher at T 60 in responders. All responders were alive 14 days post‐hIVIG infusion, and their mortality rate was significantly lower compared with nonresponders.

Conclusions

Responder dogs had an excellent 14‐day survival rate. Serum T 24 IgG and serum T 24 Δ IgG concentrations accurately predicted response status at 60 hours post‐hIVIG infusion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesImmunoglobulins, IntravenousPurpura, Thrombocytopenic, IdiopathicDogsAnimalsRetrospective StudiesFemaleMaleHumansMethylprednisoloneCohort StudiesTreatment Outcome

Stichwörter der Autor:innen

ITPcanineglucocorticoidshIVIG

Substanzen

Immunoglobulins, IntravenousMethylprednisolone

Autor:innen und Institutionen

  • Division of Internal Medicine, San Marco Veterinary Clinic, Veggiano, Italy.
  • Department of Medicina Animale, Produzione e Salute, Padua University, Legnaro, Italy.

ORCID-Profile: Andrea Zoia

Zitieren

APA

Zoia, A., Busato, F., & Drigo, M. (2024). Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.13408

Vancouver

Zoia A, Busato F, Drigo M. Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases. Journal of Veterinary Emergency and Critical Care. 2024. doi:10.1111/vec.13408

BibTeX
@article{Zoia2024,
  author = {Zoia, Andrea and Busato, Francesca and Drigo, Michele},
  title = {Retrospective evaluation of the short‐term response of human intravenous immunoglobulin therapy in the management of canine immune‐mediated thrombocytopenia (2010–2015): 27 cases},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2024},
  doi = {10.1111/vec.13408}
}
Kostenlos starten →